Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2012) 29 P1756

ICEECE2012 Poster Presentations Thyroid cancer (108 abstracts)

Role of cAMP analogs in the therapy of medullary thyroid cancer

A Dicitore 1 , E Grassi 2 , M Borghi 1, , T de Filippis 1 , L Hofland 3 , L Persani 1, & G Vitale 1,


1Istituto Auxologico Italiano, Cusano Milanino, Italy; 2Università degli Studi di Milano, Milano, Italy; 3Erasmus MC, Rotterdam, The Netherlands.


Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor highly resistant to chemo-and radiotherapy. Since several reports showed that cAMP has an antiproliferative effect on different types of solid tumors both in vitro and in vivo, we evaluated the potential anti-neoplastic activity of cAMP analogues (8-Cl-cAMP and the equimolar combination of 8-PIP-cAMP and 8-HA-cAMP) in two MTC cell lines (TT and MZ-CRC-1 that harbor C634W and M918T RET mutations, respectively).

Both 8-Cl-cAMP and 8-PIP-cAMP/8-HA-cAMP significantly inhibited MTC cells in a dose-dependent manner, evaluated by MTT proliferation assay, after 6 days of treatment. Interestingly, the antiproliferative effects for both compounds were more prominent in TT (8-Cl-cAMP: IC50=4.4 μM, maximal inhibition =−75%; 8-PIP-cAMP/8-HA-cAMP: IC50=9.7 μM, maximal inhibition =−70%) than in MZ-CRC-1 cells (8-Cl-cAMP: IC50=8.8 μM, maximal inhibition=−47%; 8-PIP-cAMP/8-HA-cAMP: IC50=12.8 μM, maximal inhibition =−63%).

After 6 days of incubation, 8-Cl-cAMP (25 μM in TT and 50 μM in MZCRC-1) significantly decreased the population of TT and MZCRC-1 cells in S phase, as suggestive for a delay in G0/G1-S phase transit, while there was no significant effect on the cell cycle during incubation with 8-PIP-cAMP/8-HA-cAMP in both cell lines. In addition, 8-Cl-cAMP induced a potent stimulation of apoptosis in TT and MZCRC-1 cells, as determined by Annexin V/propidium iodide staining and flow-cytometric analysis. While, a moderate increase of apoptotic MTC cells was observed during incubation with 8-PIP-cAMP/8-HA-cAMP.

These studies uncover a novel potential role for cAMP analogs in the treatment of MTC, thus prompting further in vivo experimentation on the efficacy and safety of these drugs.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Volume 29

15th International & 14th European Congress of Endocrinology

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts